Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, [...]
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
For the first time, U.S. CardioMEMS patients will be able [...]
BTL Expands EXOMIND® Platform with New FDA Clearances
The new clearances expand its reach to additional brain targets [...]
VertigoDx Secures FDA 510(k) Clearance for SmartVertigo® Point-of-Care Vestibular Diagnostic System
Mobile platform combines smartphone technology, a proprietary light-occluding headset, and [...]
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) [...]
Boston Scientific receives FDA clearance for SpaceOAR™ Flex Hydrogel
New addition to rectal spacing portfolio offers flexible hydrogel placement, [...]
Resivant Medical Receives U.S. Patent Protecting Novel Single-Lever, Single-Handed Applicator at the Core of the Cutiva™ PLUS Skin Closure System
The patent protects the mechanism that allows clinicians to start, [...]
NEPTUNE MEDICAL RECEIVES FDA CLEARANCE FOR TRITON ROBOTIC ENDOSCOPY SYSTEM
Triton 1 Robotic Endoscopy System 510K-Cleared for Diagnostic and Therapeutic [...]
Emboline Receives U.S. FDA 510(k) Clearance for Emboliner® Embolic Protection System
Clearance brings full cerebral and systemic embolic protection to patients [...]